DK1633374T3 - Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof - Google Patents

Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof

Info

Publication number
DK1633374T3
DK1633374T3 DK04734822T DK04734822T DK1633374T3 DK 1633374 T3 DK1633374 T3 DK 1633374T3 DK 04734822 T DK04734822 T DK 04734822T DK 04734822 T DK04734822 T DK 04734822T DK 1633374 T3 DK1633374 T3 DK 1633374T3
Authority
DK
Denmark
Prior art keywords
composition
active substance
pharmaceutically active
alkanedicarboxylic acids
hydrogen atom
Prior art date
Application number
DK04734822T
Other languages
English (en)
Inventor
Soenke Johannsen
Thomas Zollner
Original Assignee
Intendis Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intendis Gmbh filed Critical Intendis Gmbh
Application granted granted Critical
Publication of DK1633374T3 publication Critical patent/DK1633374T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK04734822T 2003-06-10 2004-05-26 Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof DK1633374T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10326722 2003-06-10
PCT/EP2004/005668 WO2004108143A1 (de) 2003-06-10 2004-05-26 Zusammensetzung aus alkandicarbonsäuren und einem pharmazeutischen wirkstoff

Publications (1)

Publication Number Publication Date
DK1633374T3 true DK1633374T3 (da) 2007-12-03

Family

ID=33495022

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04734822T DK1633374T3 (da) 2003-06-10 2004-05-26 Sammensætning af alkandicarboxylsyrer og et farmaceutisk aktivt stof

Country Status (10)

Country Link
EP (1) EP1633374B1 (da)
JP (1) JP2006527219A (da)
AT (1) ATE369866T1 (da)
CY (1) CY1107006T1 (da)
DE (1) DE502004004660D1 (da)
DK (1) DK1633374T3 (da)
ES (1) ES2293258T3 (da)
PL (1) PL1633374T3 (da)
PT (1) PT1633374E (da)
WO (1) WO2004108143A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2875404B1 (fr) * 2004-09-17 2008-10-03 Galderma Res & Dev Composition pharmaceutique pour le traitement de la rosacee
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4713394A (en) * 1986-01-17 1987-12-15 Thornfeldt Carl R Treatment of nonacne inflammatory and infectious dermatoses and hair loss
ATE210438T1 (de) * 1997-11-19 2001-12-15 Schering Ag Zusammensetzung mit azelainsäure
CN1393221A (zh) * 2001-06-22 2003-01-29 姜涛 一种治疗痤疮的药液

Also Published As

Publication number Publication date
DE502004004660D1 (de) 2007-09-27
ES2293258T3 (es) 2008-03-16
EP1633374B1 (de) 2007-08-15
WO2004108143A1 (de) 2004-12-16
JP2006527219A (ja) 2006-11-30
EP1633374A1 (de) 2006-03-15
CY1107006T1 (el) 2012-09-26
PL1633374T3 (pl) 2008-03-31
PT1633374E (pt) 2007-11-14
ATE369866T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
LU92300I2 (fr) Regorafenib et ses sels pharmaceutiquement acceptables (STIVARGA)
NO20061432L (no) N3 alkylerte benzimidazolederivater som MEK-inhibitorer
BR122018007328B8 (pt) composto, composição farmaceutica e uso do dito composto
NO20055977L (no) Nye benzimidazolderivater
UA107324C2 (uk) Похідні 1,2,3-триазолу для застосування як інгібіторів стеароїл-coa десатурази
DE60322425D1 (de) Antikrebszubereitung enthaltend dmxaa
NZ580226A (en) Dimer compounds as inhibitors of iap
BR112012026948A2 (pt) composto, composição farmacêutica, e, métodos para melhorar o metabolismo ósseo, para previnir ou tratar uma doença associada com metabolismo ósseo e para previnir ou tratar osteoporose.
MX2008014101A (es) Acidos carboxilicos sustituidos con 4,5-difenil-pirimidinilamino, metodo para su produccion y su uso como medicamentos.
CY1109519T1 (el) Κεκορεσμενες και ακορεστες 3-πυριδυλο-βενζοκυκλοαλκυλομεθυλαμινες για τη θεραπεια πονων, καταθλιψεων και καταστασεων φοβου
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
RS53887B1 (en) TOPICAL APPLICATION FOR ACTINIC KERATOSIS
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
CY1107006T1 (el) Συνθεση απο αλκανιοδικαρβονικα οξεα και μια φαρμακευτικη ουσια
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren
DE60312682D1 (de) Methode zur behandlung von rosacea durch topische verabreichung eines cyclohexanderivats
NO20055254D0 (no) Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte
HUP0203118A2 (hu) Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SE0301884D0 (sv) New use III
ATE540920T1 (de) Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie